Large randomized clinical trials in cardiovascular disease have proliferated in the last decades. Evidence generated from these trials has substantially influenced the diagnosis and treatment of diseases such as acute myocardial infarction, heart failure, arrhythmias, coronary revascularization and chronic coronary artery disease.
Most cardiovascular trials are large and long-lasting projects, with unique challenges related to enrolment and retention. Moreover, the increasing complexity of trials in this area and the escalating regulatory requirements pose significant challenges in terms of costs and timelines. OPIS scientific and operational expertise in this area is key for the implementation and efficient and cost-effective management of studies.
More than 70 studies managed
Indications: Coronary artery disease, Deep vein thrombosis, Granulomatosis with polyangiitis (Wegener’s), Heart Failure, Hypertension, Ischemic stroke, Left ventricular dysfunction, Left ventricular hypertrophy, Lower limb superficial thrombophlebitis, Myocardial infarction, Post-myocardial infarction elevated hs-CRP, Prevention of major cardiovascular events, Thromboembolism (in knee arthroplasty, Vasomotor symptoms
Phases: I, II, IIa, IIb, III, IIIb, IV
Other details: interventional and non-interventional studies in adults and children